Covered recipient · General Payments record
STEPHEN P CLEARY
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2021
$1,660.62
- Reported across 97 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2021 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $305.22 | 18 |
| Education | $6.96 | 1 |
By paying entity
PY2021 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $155.54 | 10 |
| Mylan Pharmaceuticals Inc. | $46.39 | 3 |
| Evofem Biosciences, Inc. | $37.47 | 2 |
| CooperSurgical, Inc. | $25.77 | 1 |
| Agile Therapeutics, Inc. | $20.61 | 1 |
| Exeltis, USA Inc. | $14.70 | 1 |
| Avion Pharmaceuticals | $11.70 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2021 (19)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $13.72 | 01/11/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794265601 | CMS |
| AbbVie Inc. | $17.47 | 01/25/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794265603 | CMS |
| AbbVie Inc. | $24.34 | 04/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794265605 | CMS |
| AbbVie Inc. | $19.85 | 04/06/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794265607 | CMS |
| AbbVie Inc. | $6.96 | 04/07/2021 | Education | Undisputed | 01/23/2026 | 794265609 | CMS |
| AbbVie Inc. | $14.46 | 05/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794265611 | CMS |
| AbbVie Inc. | $13.43 | 06/15/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794265613 | CMS |
| AbbVie Inc. | $17.47 | 07/09/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794265615 | CMS |
| AbbVie Inc. | $14.34 | 08/03/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794265617 | CMS |
| AbbVie Inc. | $13.50 | 09/30/2021 | Food and Beverage | Undisputed | 01/23/2026 | 794265619 | CMS |
| Agile Therapeutics, Inc. | $20.61 | 06/22/2021 | Food and Beverage | Undisputed | 01/23/2026 | 849810371 | CMS |
| Avion Pharmaceuticals | $11.70 | 03/08/2021 | Food and Beverage | Undisputed | 01/23/2026 | 845421903 | CMS |
| CooperSurgical, Inc. | $25.77 | 05/05/2021 | Food and Beverage | Undisputed | 01/23/2026 | 826653117 | CMS |
| Evofem Biosciences, Inc. | $17.42 | 08/13/2021 | Food and Beverage | Undisputed | 01/23/2026 | 855182363 | CMS |
| Evofem Biosciences, Inc. | $20.05 | 09/23/2021 | Food and Beverage | Undisputed | 01/23/2026 | 855182365 | CMS |
| Exeltis, USA Inc. | $14.70 | 02/16/2021 | Food and Beverage | Undisputed | 01/23/2026 | 806170521 | CMS |
| Mylan Pharmaceuticals Inc. | $12.14 | 04/28/2021 | Food and Beverage | Undisputed | 01/23/2026 | 965461487 | CMS |
| Mylan Pharmaceuticals Inc. | $18.15 | 06/01/2021 | Food and Beverage | Undisputed | 01/23/2026 | 965462839 | CMS |
| Mylan Pharmaceuticals Inc. | $16.10 | 07/14/2021 | Food and Beverage | Undisputed | 01/23/2026 | 965464249 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021
- Generated from
- OP_DTL_GNRL_PGYR2021_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.